Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspectiveLuke J. Ney, Esben Strodl, Wọlé Akóṣílè et al.|Expert Review of Clinical Pharmacology|2023Cited by 9
Australian clinical feasibility considerations for treatment of PTSD with cannabinoid-augmented exposure therapyLuke J. Ney, Esben Strodl, Matthew N. Hill et al.|Australian & New Zealand Journal of Psychiatry|2023Cited by 3
Resilience to Substance Use Disorder Following Childhood Maltreatment: Association With Peripheral Biomarkers of Endocannabinoid Function and Neural Indices of Emotion RegulationIrene Perini, Markus Heilig, Raegan Mazurka et al.|Biological Psychiatry|2023Cited by 1